Personnel Information

写真a

YOSHIFUJI Kota


Job title

Assistant Professor

Birth date

1986

Mail Address

yoshhema@tmd.ac.jp

To the head of this page.▲

Graduating School 【 display / non-display 】

  • Kyoto Prefectural University of Medicine, Faculty of Medicine, 2012.03, Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • Tokyo Medical and Dental University, Graduate School, Division of Medicine, Doctor's Course, 2022.03, Completed

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2019.04
    -
    2022.03
    Tokyo Medical and Dental University， Graduate School of Medical and Dental Sciences， Medical and Dental Sciences， Division of Advanced Therapeutic Sciences， Department of Hematology， Graduate Student
  • 2021.11
    -
    Now
    Institute of Science Tokyo， (Old Organization)Medical Hospital， Hospital Departments， Department of Internal Medicine， Hematology， Assistant Professor
  • 2022.04
    -
    2024.09
    Tokyo Medical and Dental University， Tokyo Medical and Dental University， Division of Clinical Medicine， Department of Internal Medicine， Hematology， Assistant Professor
  • 2024.10
    -
    Now
    Institute of Science Tokyo， -， Institute of Science Tokyo Hospital， Department of Internal Medicine， Hematology， Assistant Professor
  • 2025.01
    -
    Now
    Institute of Science Tokyo， -， Graduate Schools， Advanced Therapeutic Sciences， Department of Hematology， Assistant Professor
To the head of this page.▲

Qualification Acquired 【 display / non-display 】

  • Doctor

To the head of this page.▲
 

Published Papers & Misc 【 display / non-display 】

  1. Hiromi Hayashi, Takeo Yamagiwa, Junya Kanda, Takayuki Ishikawa, Masashi Sawa, Yasuko Miyahara, Takayoshi Tachibana, Mitsumasa Watanabe, Yasunori Ueda, Yasuhiko Tsutsumi, Kazunori Imada, Shin-Ichiro Fujiwara, Tomomi Toubai, Kota Yoshifuji, Hirokazu Hirata, Hiroshi Kawabata, Masaaki Tsuji, Satoshi Wakita, Hiroki Yokoyama, Toshiyuki Kitano, Kazunori Murai, Yoshihisa Kataoka, Eri Kawata, Shun-Ichi Kimura, Ryusuke Yamamoto, Kotaro Miyao, Daisuke Nakayama, Akihiko Izumi, Takahito Kawata, Yoshiyuki Onda, Takashi Sakamoto, Chisaki Mizumoto, Toshio Kitawaki, Kouhei Yamashita, Atsushi Yonezawa, Tomoya Kawakami, Shunsaku Nakagawa, Risa Taniguchi, Tomohiro Terada, Akifumi Takaori-Kondo. Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemia. Sci Rep. 2026.02; ( PubMed, DOI )

  2. Tomotaka Suzuki, Tomoyasu Jo, Kota Yoshifuji, Tadakazu Kondo, Noriko Doki, Yoshinobu Kanda, Tetsuya Nishida, Yasushi Onishi, Noboru Asada, Takahiro Fukuda, Masashi Sawa, Yuta Hasegawa, Kentaro Serizawa, Shuichi Ota, Masatsugu Tanaka, Makoto Yoshimitsu, Yoshiko Atsuta, Junya Kanda. Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT. Br J Haematol. 2026.01; 208 (1): 219-228. ( PubMed, DOI )

  3. Kentaro Yamaguchi, Junji Koya, Kota Mizuno, Yosuke Mizukami, Kota Yoshifuji, Yuki Saito, Mariko Tabata, Sumito Shingaki, Mitsuhiro Yuasa, Yuta Ito, Kazutaka Nakashima, Kostiantyn Dreval, Ryan D Morin, Kenichi Chiba, Ai Okada, Yuichi Shiraishi, Koichi Murakami, Yasunori Kogure, Koichi Ohshima, Keisuke Kataoka. In vivo CRISPR screening reveals cooperation of KMT2D and TP53 deficiencies in B-cell lymphomagenesis. Blood Adv. 2025.10; 9 (19): 5040-5055. ( PubMed, DOI )

  4. Akihiko Izumi, Takayoshi Tachibana, Hiroto Ishii, Shin-Ichiro Fujiwara, Yuho Najima, Chikako Ohwada, Kota Yoshifuji, Yuto Hibino, Masatsugu Tanaka, Shinichi Kako, Shun-Ichi Kimura, Masaharu Tamaki, Shingo Yano, Hiroki Yokoyama, Daisuke Minakata, Shokichi Tsukamoto, Emiko Sakaida, Noriko Doki, Akira Yokota, Takuya Miyazaki, Nobuyuki Aotsuka, Yoshinobu Kanda. Prognostic Value of C-Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma. Hematol Oncol. 2025.09; 43 (5): e70136. ( PubMed, DOI )

  5. Satoshi Yamasaki, Shohei Mizuno, Kota Yoshifuji, Eri Matsuki, Masashi Sawa, Takashi Akasaka, Naoyuki Uchida, Hitoji Uchiyama, Keisuke Kataoka, Nobuhiro Hiramoto, Yoshinobu Kanda, Kazuya Ishiwata, Toshio Wakayama, Takahiro Fukuda, Makoto Yoshimitsu, Makoto Onizuka, Marie Ohbiki, Yoshiko Atsuta, Ritsuro Suzuki, Shinichi Kako. Autologous stem cell transplantation from 2011 to 2022 in Japanese patients aged ≥ 65 years with relapsed or refractory diffuse large B-cell lymphoma. Ann Hematol. 2025.08; 104 (8): 4189-4199. ( PubMed, DOI )

  6. Yasumasa Nakata, Fumihiko Ouchi, Kota Yoshifuji, Daichi Sadato, Kouhei Yamamoto, Yuriko Kawase, Takehiko Mori. Comprehensive Genetic Analysis of Central Nervous System Involvement in Mycosis Fungoides: A Case Report. EJHaem. 2025.08; 6 (4): e70118. ( PubMed, DOI )

  7. Kota Yoshifuji, Yotaro Motomura, Makiko Saito, Genji Kawade, Shiori Watabe, Kouhei Yamamoto, Mai Soejima, Ayako Nogami, Satoru Aoyama, Takehiko Mori, Toshikage Nagao. Tumor progression locus 2, a new potential prognostic factor and therapeutic target in activated B-cell-like diffuse large B-cell lymphoma. Blood Cancer J. 2025.05; 15 (1): 95. ( PubMed, DOI )

  8. Satoshi Kaito, Yuho Najima, Daichi Sadato, Chizuko Hirama, Yuya Kishida, Akihito Nagata, Tatsuya Konishi, Yuta Yamada, Shuhei Kurosawa, Kota Yoshifuji, Shuichi Shirane, Naoki Shingai, Takashi Toya, Hiroaki Shimizu, Kyoko Haraguchi, Takeshi Kobayashi, Hironori Harada, Yoshiki Okuyama, Yuka Harada, Noriko Doki. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies. Bone Marrow Transplant. 2024.08; 59 (8): 1169-1175. ( PubMed, DOI )

  9. Yoshifuji K, Sadato D, Toya T, Motomura Y, Hirama C, Takase H, Yamamoto K, Harada Y, Mori T, Nagao T. Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma. Haematologica. 2024.06; ( PubMed, DOI )

  10. Umezawa, Y; Yoshifuji, K; Tanaka, K; Nogami, A; Nagano, K; Tsuji, A; Nagao, T; Yamamoto, M; Kajiwara, M; Tohda, S; Mori, T. Impact of BK polyomavirus viremia on the outcomes of allogeneic hematopoietic stem cell transplantation ANNALS OF HEMATOLOGY. 2024.05; 103 (5): 1737-1744. ( PubMed, DOI )

  11. Motomura, Y; Yoshifuji, K; Tachibana, T; Takase, H; Arai, A; Tanaka, K; Okada, K; Nogami, A; Umezawa, Y; Sakashita, C; Yamamoto, M; Mori, T; Nagao, T. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma BRITISH JOURNAL OF HAEMATOLOGY. 2023.12; ( PubMed, DOI )

  12. Nagao T, Yoshifuji K, Sadato D, Motomura Y, Saito M, Yamamoto K, Yamamoto K, Nogami A. Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12. Experimental hematology. 2022.12; 116 37-49. ( PubMed, DOI )

  13. Yoshifuji Kota, Sasaki Koji. Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia FRONTIERS IN ONCOLOGY. 2022.10; 12 1021662. ( PubMed, DOI )

  14. Fukuhara Suguru, Oshikawa-Kumade Yuji, Kogure Yasunori, Shingaki Sumito, Kariyazono Hirokazu, Kikukawa Yoshiya, Koya Junji, Saito Yuki, Tabata Mariko, Yoshifuji Kota, Mizuno Kota, Miyagi-Maeshima Akiko, Matsushita Hiromichi, Sugiyama Masanaka, Ogawa Chitose, Inamoto Yoshihiro, Fukuda Takahiro, Sugano Masato, Yamauchi Nobuhiko, Minami Yosuke, Hirata Makoto, Yoshida Teruhiko, Kohno Takashi, Kohsaka Shinji, Mano Hiroyuki, Shiraishi Yuichi, Ogawa Seishi, Izutsu Koji, Kataoka Keisuke. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies CANCER SCIENCE. 2022.08; 113 (8): 2763-2777. ( DOI )

  15. Kogure Yasunori, Kameda Takuro, Koya Junji, Yoshimitsu Makoto, Nosaka Kisato, Yasunaga Jun-ichirou, Imaizumi Yoshitaka, Watanabe Mizuki, Saito Yuki, Ito Yuta, McClure Marni B., Tabata Mariko, Shingaki Sumito, Yoshifuji Kota, Chiba Kenichi, Okada Ai, Kakiuchi Nobuyuki, Nannya Yasuhito, Kamiunten Ayako, Tahira Yuki, Akizuki Keiichi, Sekine Masaaki, Shide Kotaro, Hidaka Tomonori, Kubuki Yoko, Kitanaka Akira, Hidaka Michihiro, Nakano Nobuaki, Utsunomiya Atae, Sica R. Alejandro, Acuna-Villaorduna Ana, Janakiram Murali, Shah Urvi, Ramos Juan Carlos, Shibata Tatsuhiro, Takeuchi Kengo, Takaori-Kondo Akifumi, Miyazaki Yasushi, Matsuoka Masao, Ishitsuka Kenji, Shiraishi Yuichi, Miyano Satoru, Ogawa Seishi, Ye B. Hilda, Shimoda Kazuya, Kataoka Keisuke. Whole-genome landscape of adult T-cell leukemia/lymphoma BLOOD. 2022.02; 139 (7): 967-982.

  16. Konishi Tatsuya, Kusakabe Shinsuke, Hino Akihisa, Inamoto Kyoko, Yoshifuji Kota, Kiridoshi Yuko, Takeshita Kozue, Sasajima Satoshi, Toya Takashi, Igarashi Aiko, Najima Yuho, Kobayashi Takeshi, Doki Noriko, Motooka Daisuke, Nakamura Shota, Suyama Masahiro, Suda Wataru, Shiota Atsushi, Atarashi Koji, Hattori Masahira, Honda Kenya, Yokota Takafumi, Ohashi Kazuteru, Shibayama Hirohiko, Fukushima Kentaro, Kakihana Kazuhiko. Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease BONE MARROW TRANSPLANTATION. 2021.07; 56 (7): 1728-1731. ( DOI )

  17. Kota Yoshifuji, Takashi Toya, Noriyo Yanagawa, Fumikazu Sakai, Akihito Nagata, Noritaka Sekiya, Kazuteru Ohashi, Noriko Doki. CT classification of acute myeloid leukemia with pulmonary infiltration Japanese Journal of Radiology. 2021.06; 39 (11): 1049-1058. ( PubMed, DOI )

  18. Kota Yoshifuji, Kyoko Inamoto, Yuko Kiridoshi, Kozue Takeshita, Satoshi Sasajima, Yukiko Shiraishi, Yuko Yamashita, Yuko Nisaka, Yukari Ogura, Rie Takeuchi, Takashi Toya, Aiko Igarashi, Yuho Najima, Noriko Doki, Takeshi Kobayashi, Kazuteru Ohashi, Wataru Suda, Koji Atarashi, Atsushi Shiota, Masahira Hattori, Kenya Honda, Kazuhiko Kakihana. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020.10; 4 (19): 4607-4617. ( PubMed, DOI )

  19. 古屋 淳史, 斎藤 優樹, 亀田 拓郎, 木暮 泰寛, McClure Marni B., 新垣 清登, 吉藤 康太, 田畑 真梨子, 下田 和哉, 片岡 圭亮. がんの一細胞生物学　マルチオミクス単一細胞解析によるHTLV-1感染状態およびATLにおける細胞動態の網羅的解明 日本癌学会総会記事. 2020.10; 79回 S12-3. ( ichushi )

  20. 田畑 真梨子, 佐藤 悠佑, 木暮 泰寛, McClure Marni B., 斎藤 優樹, 新垣 清登, 吉藤 康太, 古屋 淳史, 河野 隆志, 白石 友一, 久米 春喜, 片岡 圭亮. がん分子標的治療薬・がん免疫治療薬への抵抗性に関わる分子機構とその克服　遺伝性淡明細胞型腎細胞癌における腫瘍内または腫瘍間の遺伝的、免疫的不均一性 日本癌学会総会記事. 2020.10; 79回 S4-3. ( ichushi )

  21. Saito Yuki, Koya Junji, Araki Mitsugu, Kogure Yasunori, Shingaki Sumito, Tabata Mariko, McClure Marni B., Yoshifuji Kota, Matsumoto Shigeyuki, Isaka Yuta, Tanaka Hiroko, Kanai Takanori, Miyano Satoru, Shiraishi Yuichi, Okuno Yasushi, Kataoka Keisuke. Landscape and function of multiple mutations within individual oncogenes NATURE. 2020.06; 582 (7810): 95-+. ( DOI )

  22. Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed, DOI )

  23. Kota Yoshifuji, Takashi Toya, Hiroto Adachi, Masahiro Fujita, Atsushi Wada, Ryosuke Konuma, Yuya Kishida, Tatsuya Konishi, Akihito Nagata, Yuta Yamada, Satoshi Kaito, Takuma Kumagai, Kyoko Inamoto, Megumi Akiyama, Aiko Igarashi, Yuho Najima, Noriko Doki, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kazuteru Ohashi. Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide. Int J Hematol. 2019.07; 110 (1): 115-118. ( PubMed, DOI )

  24. 内田 智之, 土岐 典子, 岸田 侑也, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝. Ph+ALLに対する同種造血幹細胞移植後のチロシンキナーゼ阻害剤投与の実際(Clinical impact of TKI therapy after allo-HSCT for Ph+ALL) 臨床血液. 2018.09; 59 (9): 1571. ( ichushi )

  25. 永田 啓人, 名島 悠峰, 岸田 侑也, 小西 達矢, 山田 裕太, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 武藤 秀治, 土岐 典子, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝. 造血幹細胞移植患者における二次癌治療成績の解析(The clinical outcomes of second primary malignancy after allogeneic stem cell transplantation) 臨床血液. 2018.09; 59 (9): 1543. ( ichushi )

  26. 山田 裕太, 武藤 秀治, 岸田 侑也, 小西 達矢, 永田 啓人, 海渡 智史, 黒澤 修兵, 白根 脩一, 吉藤 康太, 稲本 恭子, 内田 智之, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 小林 武, 土岐 典子, 垣花 和彦, 坂巻 壽, 大橋 一輝. 急性骨髄性白血病加療中に多発肝炎症性偽腫瘍を呈した一例(Multiple inflammatory pseudotumors of the liver associated with acute myeloid leukemia) 臨床血液. 2018.09; 59 (9): 1768. ( ichushi )

  27. 小西 達矢, 土岐 典子, 岸田 侑也, 永田 啓人, 山田 裕太, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝. 急性骨髄性白血病に対する同種造血幹細胞移植におけるGeriatric nutritional risk indexと予後(Clinical impact of geriatric nutritional risk index of allogeneic-HSCT for AML patients) 臨床血液. 2018.09; 59 (9): 1553. ( ichushi )

  28. 海渡 智史, 遠矢 嵩, 中島 祐二朗, 田口 歩, 岸田 侑也, 小西 達矢, 永田 啓人, 山田 裕太, 黒澤 修兵, 吉藤 康太, 白根 脩一, 稲本 恭子, 内田 智之, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 土岐 典子, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝. 同種造血幹細胞移植後サイトメガロウイルス再活性化の予測(Prediction of CMV reactivation after allogeneic stem cell transplantation using machine learning) 臨床血液. 2018.09; 59 (9): 1633. ( ichushi )

  29. 白根 脩一, 名島 悠峰, 福島 一彰, 関谷 紀貴, 岸田 侑也, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 武藤 秀治, 小林 武, 土岐 典子, 垣花 和彦, 坂巻 壽, 大橋 一輝. 再発難治急性リンパ性白血病に合併した中枢神経系ムコール症(Cerebral mucormycosis complicated with relapsed-refractory acute lymphoblastic leukemia) 臨床血液. 2018.09; 59 (9): 1688. ( ichushi )

  30. 吉藤 康太, 稲本 恭子, 垣花 和彦, 白石 由紀子, 岸田 侑也, 小西 達矢, 永田 啓人, 山田 裕太, 海渡 智史, 黒澤 修兵, 白根 脩一, 内田 智之, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 土岐 典子, 小林 武, 坂巻 壽, 大橋 一輝. プレバイオティクス摂取が移植関連合併症に与える影響について(Effect of prebiotics on transplant-related complications) 臨床血液. 2018.09; 59 (9): 1544. ( ichushi )

  31. 岸田 侑也, 土岐 典子, 中尾 眞二, 吉岡 康介, 永田 啓人, 山田 裕太, 小西 達矢, 海渡 智史, 黒澤 修兵, 吉藤 康太, 白根 脩一, 内田 智之, 稲本 恭子, 遠矢 嵩, 五十嵐 愛子, 名島 悠峰, 武藤 秀治, 小林 武, 垣花 和彦, 坂巻 壽, 大橋 一輝. フルダラビン前処置による造血幹細胞移植後、自己造血回復し、AIHAを発症したAA-PNH(AIHA on autologous hematologic recovery after conditioning with fludarabine for allo-HSCT in AA-PNH) 臨床血液. 2018.09; 59 (9): 1815. ( ichushi )

  32. 秋山　めぐみ,吉藤　康太,福田　哲也,東田　修二,三木　徹,三浦　修,山本　正英. 自己免疫性溶血性貧血に対するprednisolone治療中に発症した皮膚症状を伴わない劇症型内臓播種性VZV感染症 臨床血液. 2016.04; 57 (4): 467-471. ( PubMed, DOI )

▼display all

To the head of this page.▲

Conference Activities & Talks 【 display / non-display 】

  1. 野上 彩子, 倉田 盛人, 田口 登和子, 小山 祥美, 永野 勝稔, 田中 圭祐, 吉藤 康太, 梅澤 佳央, 市村 直也, 東田 修二, 森 毅彦. 尿セルブロックを用いた出血性膀胱炎起因ウイルスの病理学的同定法の有用性. 日本血液学会学術集会 2023.10.01

  2. 泉 陽彦, 立花 崇孝, 賀古 真一, 石井 敬人, 藤原 慎一郎, 堺田 恵美子, 名島 悠峰, 土岐 典子, 日比野 勇人, 横田 朗, 宮崎 拓也, 青墳 信之, 松本 憲二, 塚田 信弘, 半田 寛, 片岡 圭亮, 臼杵 憲祐, 高橋 聡, 篠原 明仁, 高田 覚, 吉藤 康太, 大和田 千佳子, 神田 喜伸. 悪性リンパ腫における同種移植前CRP/Platelet比の臨床的意義. 日本血液学会学術集会 2023.10.01

  3. 本村 鷹多朗, 吉藤 康太, 貞任 大地, 野上 彩子, 齊藤 真貴子, 岡田 啓五, 青山 慧, 森 毅彦, 長尾 俊景. 新規GCB-DLBCL細胞株TMD13の樹立と特性評価(Establishment and characterization of TMD13. a novel GCB-type DLBCL cell line). 日本リンパ網内系学会会誌 2023.06.01

  4. Kota Yoshifuji, Yotaro Motomura, Makiko Saito, Ayako Nogami, Genji Kawade, Shiori Watabe, Kouhei Yamamoto, Takahiko Mori, Toshikage Nagao.. TPL2, a New Prognostic Factor and a Potential Therapeutic Target in ABC-DLBCL.. 64th ASH Annual Meeting and Exposition. 2022.12.11 New Orleans

  5. 山口 健太郎, 古屋 淳史, 水野 洸太, 吉藤 康太, 伊藤 勇太, 湯淺 光博, 斎藤 優樹, 田畑 真梨子, 新垣 清登, 木暮 泰寛, 中嶋 一貴, 大島 孝一, 片岡 圭亮. High-throughput screening to elucidate in vivo oncogenicity of lymphoma-related genetic alterations(和訳中). 日本リンパ網内系学会会誌 2022.06.01

  6. Kentaro Yamaguchi, Junji Koya, Kota Yoshifuji, Yuta Ito, Mitsuhiro Yuasa, Yuki Saito, Makiko Tabata, Sumito Shingaki, Yasuhiro Kogure, Kazutaka Nakashima, Koichi Oshima, Keisuke Kataoka . High-throughput screening to elucidate in vivo oncogenicity of lymphoma-related genetic alterations. The 83rd annual meeting of Japanese society of hematology 2021.09.24

  7. Tomoko Yamashita, Hiroki Tsutsumi, Kota Yoshifuji, Tatsuya Saito, Yoshihiro Umezawa, Ayako Nogami, Ken Watanabe, Toshikage Nagao, Chizduko Sakashita, Masahide Yamamoto, Ayako Arai, Norihiko Kawamata, Osamu Miura, Tetsuya Fukuda. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 11q Deletion. 第79回日本血液学会学術集会 2017.10.22

▼display all

To the head of this page.▲